vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and UNITED SECURITY BANCSHARES (UBFO). Click either name above to swap in a different company.

UNITED SECURITY BANCSHARES is the larger business by last-quarter revenue ($13.5M vs $8.1M, roughly 1.7× Arcellx, Inc.). UNITED SECURITY BANCSHARES runs the higher net margin — 25.2% vs -766.0%, a 791.2% gap on every dollar of revenue. On growth, UNITED SECURITY BANCSHARES posted the faster year-over-year revenue change (13.6% vs -79.3%). UNITED SECURITY BANCSHARES produced more free cash flow last quarter ($19.8M vs $-63.9M). Over the past eight quarters, UNITED SECURITY BANCSHARES's revenue compounded faster (3.0% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

United Security Bancshares is a bank holding company headquartered in Fresno, California. It operates 11 branches.

ACLX vs UBFO — Head-to-Head

Bigger by revenue
UBFO
UBFO
1.7× larger
UBFO
$13.5M
$8.1M
ACLX
Growing faster (revenue YoY)
UBFO
UBFO
+92.9% gap
UBFO
13.6%
-79.3%
ACLX
Higher net margin
UBFO
UBFO
791.2% more per $
UBFO
25.2%
-766.0%
ACLX
More free cash flow
UBFO
UBFO
$83.7M more FCF
UBFO
$19.8M
$-63.9M
ACLX
Faster 2-yr revenue CAGR
UBFO
UBFO
Annualised
UBFO
3.0%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
UBFO
UBFO
Revenue
$8.1M
$13.5M
Net Profit
$-62.3M
$3.4M
Gross Margin
Operating Margin
-847.6%
31.5%
Net Margin
-766.0%
25.2%
Revenue YoY
-79.3%
13.6%
Net Profit YoY
-765.1%
36.8%
EPS (diluted)
$-1.13
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
UBFO
UBFO
Q4 25
$13.5M
Q3 25
$14.0M
Q2 25
$12.6M
Q1 25
$8.1M
$13.7M
Q4 24
$15.3M
$11.9M
Q3 24
$26.0M
$13.8M
Q2 24
$27.4M
$13.0M
Q1 24
$39.3M
$12.8M
Net Profit
ACLX
ACLX
UBFO
UBFO
Q4 25
$3.4M
Q3 25
$4.0M
Q2 25
$2.2M
Q1 25
$-62.3M
$2.7M
Q4 24
$-47.1M
$2.5M
Q3 24
$-25.9M
$3.8M
Q2 24
$-27.2M
$4.3M
Q1 24
$-7.2M
$4.2M
Operating Margin
ACLX
ACLX
UBFO
UBFO
Q4 25
31.5%
Q3 25
40.3%
Q2 25
24.0%
Q1 25
-847.6%
27.5%
Q4 24
-348.2%
27.5%
Q3 24
-129.1%
37.1%
Q2 24
-127.8%
46.4%
Q1 24
-40.3%
45.9%
Net Margin
ACLX
ACLX
UBFO
UBFO
Q4 25
25.2%
Q3 25
28.7%
Q2 25
17.2%
Q1 25
-766.0%
19.6%
Q4 24
-308.4%
20.9%
Q3 24
-99.4%
27.7%
Q2 24
-99.3%
33.0%
Q1 24
-18.3%
32.6%
EPS (diluted)
ACLX
ACLX
UBFO
UBFO
Q4 25
$0.18
Q3 25
$0.23
Q2 25
$0.13
Q1 25
$-1.13
$0.16
Q4 24
$-0.87
$0.14
Q3 24
$-0.48
$0.22
Q2 24
$-0.51
$0.25
Q1 24
$-0.14
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
UBFO
UBFO
Cash + ST InvestmentsLiquidity on hand
$543.3M
$264.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$139.7M
Total Assets
$648.1M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
UBFO
UBFO
Q4 25
$264.2M
Q3 25
$211.1M
Q2 25
$199.5M
Q1 25
$543.3M
$198.4M
Q4 24
$587.4M
$216.9M
Q3 24
$574.3M
$216.8M
Q2 24
$516.7M
$166.3M
Q1 24
$573.9M
$168.6M
Stockholders' Equity
ACLX
ACLX
UBFO
UBFO
Q4 25
$139.7M
Q3 25
$137.4M
Q2 25
$134.3M
Q1 25
$416.9M
$132.9M
Q4 24
$454.8M
$130.4M
Q3 24
$483.0M
$132.9M
Q2 24
$487.2M
$127.3M
Q1 24
$496.6M
$124.2M
Total Assets
ACLX
ACLX
UBFO
UBFO
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$648.1M
$1.2B
Q4 24
$711.3M
$1.2B
Q3 24
$764.9M
$1.3B
Q2 24
$734.3M
$1.2B
Q1 24
$779.7M
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
UBFO
UBFO
Operating Cash FlowLast quarter
$-63.1M
$22.1M
Free Cash FlowOCF − Capex
$-63.9M
$19.8M
FCF MarginFCF / Revenue
-786.4%
146.0%
Capex IntensityCapex / Revenue
9.6%
16.8%
Cash ConversionOCF / Net Profit
6.46×
TTM Free Cash FlowTrailing 4 quarters
$-122.5M
$36.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
UBFO
UBFO
Q4 25
$22.1M
Q3 25
$7.0M
Q2 25
$8.7M
Q1 25
$-63.1M
$3.0M
Q4 24
$-46.0M
$19.6M
Q3 24
$30.7M
$5.4M
Q2 24
$-36.2M
$2.3M
Q1 24
$-31.9M
$7.4M
Free Cash Flow
ACLX
ACLX
UBFO
UBFO
Q4 25
$19.8M
Q3 25
$6.1M
Q2 25
$8.1M
Q1 25
$-63.9M
$2.9M
Q4 24
$-47.5M
$18.6M
Q3 24
$28.4M
$5.3M
Q2 24
$-39.5M
$2.0M
Q1 24
$-38.3M
$7.0M
FCF Margin
ACLX
ACLX
UBFO
UBFO
Q4 25
146.0%
Q3 25
43.7%
Q2 25
64.3%
Q1 25
-786.4%
21.2%
Q4 24
-311.3%
156.0%
Q3 24
109.2%
38.1%
Q2 24
-144.1%
15.5%
Q1 24
-97.7%
54.8%
Capex Intensity
ACLX
ACLX
UBFO
UBFO
Q4 25
16.8%
Q3 25
6.0%
Q2 25
4.6%
Q1 25
9.6%
0.9%
Q4 24
9.8%
8.7%
Q3 24
8.8%
0.7%
Q2 24
11.7%
2.2%
Q1 24
16.4%
3.6%
Cash Conversion
ACLX
ACLX
UBFO
UBFO
Q4 25
6.46×
Q3 25
1.73×
Q2 25
4.01×
Q1 25
1.13×
Q4 24
7.87×
Q3 24
1.40×
Q2 24
0.54×
Q1 24
1.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons